News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioLine Launches High Performance SensiFAST™ cDNA Synthesis Kit



2/7/2014 8:30:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CINCINNATI--(BUSINESS WIRE)--Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the SensiFASTTM cDNA synthesis kit. Powered by a newly developed Reverse Transcriptase enzyme with enhanced properties and in combination with the unique TransAmp™ buffer; SensiFASTTM cDNA synthesis kit is the choice for scientists who need consistent, unbiased, first-strand cDNA synthesis necessary for high sensitivity real-time PCR experiments.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
BioLine
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES